A pilot study of the use of epidermal growth factor in pediatric short bowel syndrome

This publication has 25 references indexed in Scilit:

• Effect of epidermal growth factor administration on intestinal cell proliferation, crypt fission and polyp formation in multiple intestinal neoplasia (Min) mice
  Clinical Science, 2003
• Segregation of receptor and ligand regulates activation of epithelial growth factor receptor
  Nature, 2003
• 3–0 methylglucose absorption in vivo correlates with nutrient absorption and intestinal surface area in experimental short bowel syndrome
  Journal of Parenteral and Enteral Nutrition, 2003
• Prophylactic Use of Epidermal Growth Factor Reduces Ischemia/Reperfusion Intestinal Damage
  The American Journal of Pathology, 2002
• Gastrointestinal cell proliferation and crypt fission are separate but complementary means of increasing tissue mass following infusion of epidermal growth factor in rats
  Gut, 2001
• Potency and stability of C terminal truncated human epidermal growth factor
  Gut, 2000
• The effect of epidermal growth factor on brush border surface area and function in the distal remnant following resection in the rabbit
  Gut, 1999
• Adaptation after small bowel resection is attenuated by sialoadenectomy: The role for endogenous epidermal growth factor
  Surgery, 1998
• The epidermal growth factor receptor (EGF-R) is present on the basolateral, but not the apical, surface of enterocytes in the human gastrointestinal tract.
  Gut, 1996
• INTRAVENOUS EPIDERMAL GROWTH FACTOR/UROGASTRONE INCREASES SMALL-INTESTINAL CELL PROLIFERATION IN CONGENITAL MICROVILLOUS ATROPHY
  The Lancet, 1985